2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope

Heart Rhythm

Volumn 12, Issue 6, 2015, Pages e41-e63

  Sheldon, Robert S ^a   Grubb, Blair P ^b   Olshansky, Brian ^c   Shen, Win Kuang ^d   Calkins, Hugh ^e   Brignole, Michele ^f   Raj, Satish R ^a,t   Krahn, Andrew D ^g   Morillo, Carlos A ^h   Stewart, Julian M ⁱ   Sutton, Richard ^j   Sandroni, Paola ^k   Friday, Karen J ^l   Hachul, Denise Tessariol ^m   Cohen, Mitchell I ⁿ   Lau, Dennis H ^o   Mayuga, Kenneth A ^p   Moak, Jeffrey P ^q   Sandhu, Roopinder K ^r   Kanjwal, Khalil ^s  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^b UNIVERSITY OF TOLEDO   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d MAYO CLINIC   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f DEPARTMENT OF CARDIOLOGY   (Italy)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ NEW YORK MEDICAL COLLEGE   (United States)

^j NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^k MAYO CLINIC   (United States)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF SÃO PAULO   (Brazil)

ⁿ UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^o UNIVERSITY OF ADELAIDE   (Australia)

^p LERNER RESEARCH INSTITUTE   (United States)

^q CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^r UNIVERSITY OF ALBERTA   (Canada)

^s CENTRAL MICHIGAN UNIVERSITY   (United States)

^t VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; IVABRADINE; MIDODRINE; SEROTONIN ANTAGONIST;

ARTIFICIAL HEART PACEMAKER; AUTONOMIC DENERVATION; CARDIOVASCULAR EFFECT; CONSENSUS; ELECTROCARDIOGRAPHY; FAINTNESS; HEART ARREST; HEART RHYTHM; HUMAN; HYPOVOLEMIA; MEDICAL SOCIETY; PHYSIOLOGY; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PREVALENCE; PRIORITY JOURNAL; REVIEW; SINUS TACHYCARDIA; TILT TABLE TEST; CHILD; CONSENSUS DEVELOPMENT; FEMALE; MALE; MIDDLE AGED; SYNCOPE, VASOVAGAL; TACHYCARDIA, SINUS;

CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; SOCIETIES, MEDICAL; SYNCOPE, VASOVAGAL; TACHYCARDIA, SINUS;

EID: 84930380140     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.03.029     Document Type: Article

References (147)

1. P. Saklani, A. Krahn, and G. Klein Syncope Circulation 127 2013 1330 1339
2. A. Moya, R. Sutton, and F. Ammirati Guidelines for the diagnosis and management of syncope (version 2009) Eur Heart J 30 2009 2631 2671
3. B. Olshansky, and R.M. Sullivan Inappropriate sinus tachycardia J Am Coll Cardiol 61 2013 793 801
4. M. Brignole, and M.H. Hamdan New concepts in the assessment of syncope J Am Coll Cardiol 59 2012 1583 1591
5. A.K. Jacobs, J.L. Anderson, and J.L. Halperin The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 64 2014 1373 1384
6. C. Blomstrom-Lundqvist, M.M. Scheinman, and E.M. Aliot ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary. a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society J Am Coll Cardiol 42 2003 1493 1531
7. M.J. Thieben, P. Sandroni, D.M. Sletten, L.M. Benrud-Larson, R.D. Fealey, S. Vernino, V.A. Lennon, W.K. Shen, and P.A. Low Postural orthostatic tachycardia syndrome: the Mayo clinic experience Mayo Clin Proc 82 2007 308 313
8. R. Schondorf, and P.A. Low Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 43 1993 132 137
9. P.A. Low, T.L. Opfer-Gehrking, S.C. Textor, E.E. Benarroch, W.K. Shen, R. Schondorf, G.A. Suarez, and T.A. Rummans Postural tachycardia syndrome (POTS) Neurology 45 1995 S19 S25
10. R. Freeman, W. Wieling, and F.B. Axelrod Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome Auton Neurosci 161 2011 46 48
11. W. Singer, D.M. Sletten, T.L. Opfer-Gehrking, C.K. Brands, P.R. Fischer, and P.A. Low Postural tachycardia in children and adolescents: what is abnormal? J Pediatr 160 2012 222 226
12. E.M. Garland, S.R. Raj, B.K. Black, P.A. Harris, and D. Robertson The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome Neurology 69 2007 790 798
13. P.A. Low, P. Sandroni, M. Joyner, and W.K. Shen Postural tachycardia syndrome (POTS) J Cardiovasc Electrophysiol 20 2009 352 358
14. D. Robertson The epidemic of orthostatic tachycardia and orthostatic intolerance Am J Med Sci 317 1999 75 77
15. R. Schondorf, J. Benoit, T. Wein, and D. Phaneuf Orthostatic intolerance in the chronic fatigue syndrome J Auton Nerv Syst 75 1999 192 201
16. R. Freeman, W. Wieling, and F.B. Axelrod Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome Clin Auton Res 21 2011 69 72
17. I. Lewis, J. Pairman, G. Spickett, and J.L. Newton Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome J Intern Med 273 2013 501 510
18. E.E. Benarroch Postural tachycardia syndrome: a heterogeneous and multifactorial disorder Mayo Clin Proc 87 2012 1214 1225
19. A.C. Peltier, E. Garland, S.R. Raj, K. Sato, B. Black, Y. Song, L. Wang, I. Biaggioni, A. Diedrich, and D. Robertson Distal sudomotor findings in postural tachycardia syndrome Clin Auton Res 20 2010 93 99
20. W. Singer, J.M. Spies, J. McArthur, J. Low, J.W. Griffin, K.K. Nickander, V. Gordon, and P.A. Low Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies Neurology 62 2004 612 618
21. P.A. Low, T.L. Opfer-Gehrking, S.C. Textor, R. Schondorf, G.A. Suarez, R.D. Fealey, and M. Camilleri Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure J Auton Nerv Syst 50 1994 181 188
22. E.R. Vogel, P. Sandroni, and P.A. Low Blood pressure recovery from Valsalva maneuver in patients with autonomic failure Neurology 65 2005 1533 1537
23. P. Sandroni, V. Novak, T.L. Opfer-Gehrking, C.A. Huck, and P.A. Low Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome Clin Auton Res 10 2000 1 5
24. G. Jacob, F. Costa, J.R. Shannon, R.M. Robertson, M. Wathen, M. Stein, I. Biaggioni, A. Ertl, B. Black, and D. Robertson The neuropathic postural tachycardia syndrome N Engl J Med 343 2000 1008 1014
25. J.M. Stewart, M.S. Medow, L.D. Montgomery, and K. McLeod Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow Am J Physiol Heart Circ Physiol 286 2004 H1216 H1222
26. J.M. Stewart, M.S. Medow, J.L. Glover, and L.D. Montgomery Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome Am J Physiol Heart Circ Physiol 290 2006 H665 H673
27. J.M. Stewart, and L.D. Montgomery Regional blood volume and peripheral blood flow in postural tachycardia syndrome Am J Physiol Heart Circ Physiol 287 2004 H1319 H1327
28. H.S.W. Tani, B.R. McPhee, T.L. Opfer-Gehrking, and P.A. Low Splanchnic and systemic circulation in the postural tachycardia syndrome Clin Auton Res 9 1999 231 232
29. D. Wallman, J. Weinberg, and A.D. Hohler Ehlers-Danlos Syndrome and Postural Tachycardia Syndrome: a relationship study J ournal Neurol Sci 340 2014 99 102
30. X.L. Wang, T.Y. Ling, M.C. Charlesworth, J.J. Figueroa, P. Low, W.K. Shen, and H.C. Lee Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome Transl Res 162 2013 34 44
31. H. Li, X. Yu, and C. Liles Autoimmune basis for postural tachycardia syndrome JAMA 3 2014 e000755
32. S.R. Raj, I. Biaggioni, P.C. Yamhure, B.K. Black, S.Y. Paranjape, D.W. Byrne, and D. Robertson Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome Circulation 111 2005 1574 1582
33. H. Abe, T. Nagatomo, K. Kohshi, T. Numata, K. Kikuchi, S. Sonoda, T. Mizuki, A. Kuroiwa, and Y. Nakashima Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome J Cardiovasc Pharmacol 36 Suppl 2 2000 S79 S82
34. A. Parsaik, T.G. Allison, W. Singer, D.M. Sletten, M.J. Joyner, E.E. Benarroch, P.A. Low, and P. Sandroni Deconditioning in patients with orthostatic intolerance Neurology 79 2012 1435 1439
35. Q. Fu, T.B. Vangundy, M.M. Galbreath, S. Shibata, M. Jain, J.L. Hastings, P.S. Bhella, and B.D. Levine Cardiac origins of the postural orthostatic tachycardia syndrome J Am Coll Cardiol 55 2010 2858 2868
36. S. Masuki, J.H. Eisenach, C.P. Johnson, N.M. Dietz, L.M. Benrud-Larson, W.G. Schrage, T.B. Curry, P. Sandroni, P.A. Low, and M.J. Joyner Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety J Appl Physiol 102 2007 896 903
37. L.M. Benrud-Larson, P. Sandroni, J.A. Haythornthwaite, T.A. Rummans, and P.A. Low Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings Health Psychol 22 2003 643 648
38. R. Winker, A. Barth, D. Bidmon, I Ponocny, M. Weber, O. Mayr, D. Robertson, A. Diedrich, R. Maier, A. Pilger, P. Haber, and H.W. Rudiger Endurance exercise training in orthostatic intolerance: a randomized, controlled trial Hypertension 45 2005 391 398
39. P.C. Rowe, H. Calkins, and K. DeBusk Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial JAMA 285 2001 52 59
40. G. Jacob, J.R. Shannon, B. Black, I. Biaggioni, R. Mosqueda-Garcia, R.M. Robertson, and D. Robertson Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia Circulation 96 1997 575 580
41. V.M. Gordon, T.L. Opfer-Gehrking, V. Novak, and P.A. Low Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome Clin Auton Res 10 2000 29 33
42. S.R. Raj, B.K. Black, I. Biaggioni, S.Y. Paranjape, M. Ramirez, W.D. Dupont, and D. Robertson Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more Circulation 120 2009 725 734
43. Q. Fu, T.B. Vangundy, S. Shibata, R.J. Auchus, G.H. Williams, and B.D. Levine Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome Hypertension 58 2011 167 175
44. C. McDonald, J. Frith, and J.L. Newton Single centre experience of ivabradine in postural orthostatic tachycardia syndrome Europace 13 2011 427 430
45. S.R. Raj, B.K. Black, I. Biaggioni, P.A. Harris, and D. Robertson Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome Circulation 111 2005 2734 2740
46. K. Kanjwal, B. Karabin, M. Sheikh, L. Elmer, Y. Kanjwal, B. Saeed, and B.P. Grubb Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience Pacing Clin Electrophysiol 34 2011 750 755
47. F.A. Gaffney, L.B. Lane, W. Pettinger, and C.G. Blomqvist Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia Chest 83 1983 436 438
48. C. Shibao, C. Arzubiaga, L.J. Roberts 2nd, S. Raj, B. Black, P. Harris, and I. Biaggioni Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders Hypertension 45 2005 385 390
49. I. Taneja, S. Bruehl, and D. Robertson Effect of modafinil on acute pain: a randomized double-blind crossover study J Clin Pharmacol 44 2004 1425 1427
50. W.K. Shen, P.A. Low, A. Jahangir, T.M. Munger, P.A. Friedman, M.J. Osborn, M.S. Stanton, D.L. Packer, R.F. Rea, and S.C. Hammill Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol 24 2001 217 230
51. E.M. Garland, and D. Robertson Chiari I malformation as a cause of orthostatic intolerance symptoms: a media myth? Am J Med 111 2001 546 552
52. O. Prilipko, A.R. Dehdashti, S. Zaim, and M. Seeck Orthostatic intolerance and syncope associated with Chiari type I malformation J Neurol Neurosurg Psychiatry 76 2005 1034 1036
53. A.M. Still, P. Raatikainen, A. Ylitalo, H. Kauma, M. Ikaheimo, Y. Antero Kesaniemi, and H.V. Huikuri Prevalence, characteristics and natural course of inappropriate sinus tachycardia Europace 7 2005 104 112
54. P.A. Chiale, H.A. Garro, J. Schmidberg, R.A. Sanchez, R.S. Acunzo, M. Lago, G. Levy, and M. Levin Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta adrenergic receptors Heart Rhythm 3 2006 1182 1186
55. P.F. Winum, G. Cayla, M. Rubini, L. Beck, and P. Messner-Pellenc A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine Pacing Clin Electrophysiol 32 2009 942 944
56. E. Romeo, N. Grimaldi, B. Sarubbi, M. D'Alto, G. Santarpia, G. Scognamiglio, M.G. Russo, and R. Calabro A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine Pediatr Cardiol 32 2011 842 845
57. P.A. Brady, P.A. Low, and W.K. Shen Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes Pacing Clin Electrophysiol 28 2005 1112 1121
58. D.J. Ewing, J.B. Irving, F. Kerr, J.A. Wildsmith, and B.F. Clarke Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function Clin Sci Mol Med 46 1974 295 306
59. C.A. Morillo, G.J. Klein, R.K. Thakur, H. Li, M. Zardini, and R. Yee Mechanism of "inappropriate" sinus tachycardia. Role of sympathovagal balance Circulation 90 1994 873 877
60. A. Castellanos, F. Moleiro, S. Chakko, H. Acosta, H. Huikuri, R.D. Mitrani, and R.J. Myerburg Heart rate variability in inappropriate sinus tachycardia Am J Cardiol 82 1998 531 534
61. H. Leon, J.C. Guzman, T. Kuusela, R. Dillenburg, M. Kamath, and C.A. Morillo Impaired baroreflex gain in patients with inappropriate sinus tachycardia J Cardiovasc Electrophysiol 16 2005 64 68
62. N.F. Marrouche, S. Beheiry, G. Tomassoni, C. Cole, D. Bash, T. Dresing, W. Saliba, A. Abdul-Karim, P. Tchou, R. Schweikert, F. Leonelli, and A. Natale Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome J Am Coll Cardiol 39 2002 1046 1054
63. R. Cappato, S. Castelvecchio, and C. Ricci Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation J oAm Coll Cardiol 60 2012 1323 1329
64. P. Ptaszynski, K. Kaczmarek, J. Ruta, T. Klingenheben, I. Cygankiewicz, and J.K. Wranicz Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia J Cardiovasc Pharmacol Ther 18 2013 338 344
65. K.S. Ganzeboom, G. Mairuhu, J.B. Reitsma, M. Linzer, W. Wieling, and N. van Dijk Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years J Cardiovasc Electrophysiol 17 2006 1172 1176
66. A. Serletis, S. Rose, A.G. Sheldon, and R.S. Sheldon Vasovagal syncope in medical students and their first-degree relatives Eur Heart J 27 2006 1965 1970
67. R.S. Sheldon, A.G. Sheldon, S.J. Connolly, C.A. Morillo, T. Klingenheben, A.D. Krahn, M.L. Koshman, and D. Ritchie Investigators of the Syncope Symptom Study and the Prevention of Syncope Trial. Age of first faint in patients with vasovagal syncope J Cardiovasc Electrophysiol 17 2006 49 54
68. G.L. Sumner, M.S. Rose, M.L. Koshman, D. Ritchie, and R.S. Sheldon Prevention of Syncope Trial I. Recent history of vasovagal syncope in a young, referral-based population is a stronger predictor of recurrent syncope than lifetime syncope burden J Cardiovasc Electrophysiol 21 2010 1375 1380
69. L.Y. Chen, B.J. Gersh, D.O. Hodge, W. Wieling, S.C. Hammill, and W.K. Shen Prevalence and clinical outcomes of patients with multiple potential causes of syncope Mayo Clin Proc 78 2003 414 420
70. M. Brignole, C. Menozzi, and A. Bartoletti A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals Eur Heart J 27 2006 76 82
71. F. D'Ascenzo, G. Biondi-Zoccai, M.J. Reed, G.Z. Gabayan, M. Suzuki, G. Costantino, R. Furlan, A. Del Rosso, F.P. Sarasin, B.C. Sun, M.G. Modena, and F. Gaita Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: an international meta-analysis Int J Cardiol 167 2013 57 62
72. G.E.F. Barón-Esquivias, A. Pedrote, A. Cayuela, S. Gómez, A. Aguilera, A. Campos, M. Fernández, J.I. Valle, M. Redondo, J.M. Fernández, A. Martínez, J. Burgos, and A. Martínez-Rubio Long-term outcome of patients with vasovagal syncope Am Heart J 147 2004 83 89
73. R. Mosqueda-Garcia, R. Furlan, J. Tank, and R. Fernandez-Violante The elusive pathophysiology of neurally mediated syncope Circulation 102 2000 2898 2906
74. G. Glick, and P.N. Yu Hemodynamic changes during spontaneous vasovagal reactions Am J Med 34 1963 42 51
75. A.D. Hargreaves, and A.L. Muir Lack of variation in venous tone potentiates vasovagal syncope Br Heart J 67 1992 486 490
76. D.E. Manyari, S. Rose, J.V. Tyberg, and R.S. Sheldon Abnormal reflex venous function in patients with neuromediated syncope J Am Coll Cardiol 27 1996 1730 1735
77. H.L. Thomson, J.J. Atherton, F.A. Khafagi, and M.P. Frenneaux Failure of reflex venoconstriction during exercise in patients with vasovagal syncope Circulation 93 1996 953 959
78. B. Verheyden, J. Liu, N. van Dijk, B.E. Westerhof, T. Reybrouck, A.E. Aubert, and W. Wieling Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerine-induced orthostatic vasovagal syncope Heart Rhythm 5 2008 1695 1701
79. J. Gisolf, B.E. Westerhof, N. van Dijk, K.H. Wesseling, W. Wieling, and J.M. Karemaker Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response J Am Coll Cardiol 44 2004 588 593
80. B. Verheyden, J. Gisolf, F. Beckers, J.M. Karemaker, K.H. Wesseling, A.E. Aubert, and W. Wieling Impact of age on the vasovagal response provoked by sublingual nitroglycerine in routine tilt testing Clin Sci 113 2007 329 337
81. Q. Fu, and B.D. Levine Pathophysiology of neurally mediated syncope: Role of cardiac output and total peripheral resistance Auton Neurosci 184 2014 24 26
82. C.A. Morillo, D.L. Eckberg, K.A. Ellenbogen, L.A. Beightol, J.B. Hoag, K.U. Tahvanainen, T.A. Kuusela, and A.M. Diedrich Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope Circulation 96 1997 2509 2513
83. R. Mosqueda-Garcia, R. Furlan, R. Fernandez-Violante, T. Desai, M. Snell, Z. Jarai, V. Ananthram, R.M. Robertson, and D. Robertson Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt J Clin Invest 99 1997 2736 2744
84. D.L. Jardine, I.C. Melton, I.G. Crozier, S. English, S.I. Bennett, C.M. Frampton, and H. Ikram Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope Am J Physiol Heart Circ Physiol 282 2002 H1804 H1809
85. W.H. Cooke, and V.A. Convertino Association between vasovagal hypotension and low sympathetic neural activity during presyncope Clin Auton Res 12 2002 483 486
86. G. Vaddadi, M.D. Esler, T. Dawood, and E. Lambert Persistence of muscle sympathetic nerve activity during vasovagal syncope Eur Heart J 31 2010 2027 2033
87. G. Vaddadi, L. Guo, M. Esler, F. Socratous, M. Schlaich, R. Chopra, N. Eikelis, G. Lambert, T. Trauer, and E. Lambert Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes Circ Arrhythm Electrophysiol 4 2011 711 718
88. R. Sheldon How to differentiate syncope from seizure Card Electrophysiol Clin 5 2013 423 431
89. N. van Dijk, K.R. Boer, N. Colman, A. Bakker, J. Stam, J.J. van Grieken, A.A. Wilde, M. Linzer, J.B. Reitsma, and W. Wieling High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment study J Cardiovasc Electrophysiol 19 2008 48 55
90. R. Sheldon, A. Hersi, D. Ritchie, M.L. Koshman, and S. Rose Syncope and structural heart disease: historical criteria for vasovagal syncope and ventricular tachycardia J Cardiovasc Electrophysiol 21 2010 1358 1364
91. R. Sheldon, S. Rose, S. Connolly, D. Ritchie, M.L. Koshman, and M. Frenneaux Diagnostic criteria for vasovagal syncope based on a quantitative history Eur Heart J 27 2006 344 350
92. R. Sheldon, S. Rose, D. Ritchie, S.J. Connolly, M.L. Koshman, M.A. Lee, M. Frenneaux, M. Fisher, and W. Murphy Historical criteria that distinguish syncope from seizures J Am Coll Cardiol 40 2002 142 148
93. R.S. Sheldon, M.L. Koshman, and W.F. Murphy Electroencephalographic findings during presyncope and syncope induced by tilt table testing Can J Cardiol 14 1998 811 816
94. J.J. Romme, N. van Dijk, K.R. Boer, P.M. Bossuyt, W. Wieling, and J.B. Reitsma Diagnosing vasovagal syncope based on quantitative history-taking: validation of the Calgary Syncope Symptom Score Eur Heart J 30 2009 2888 2896
95. V. Exposito, J.C. Guzman, M. Orava, L. Armaganijan, and C.A. Morillo Usefulness of the Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly Europace 15 2013 1210 1214
96. P. Alboni, M. Brignole, C. Menozzi, A. Raviele, A. Del Rosso, M. Dinelli, A. Solano, and N. Bottoni Diagnostic value of history in patients with syncope with or without heart disease J Am Coll Cardiol 37 2001 1921 1928
97. S. Sud, G.J. Klein, A.C. Skanes, L.J. Gula, R. Yee, and A.D. Krahn Predicting the cause of syncope from clinical history in patients undergoing prolonged monitoring Heart Rhythm 6 2009 238 243
98. A. Natale, M. Akhtar, M. Jazayeri, A. Dhala, Z. Blanck, S. Deshpande, A. Krebs, and J.S. Sra Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope Circulation 92 1995 54 58
99. A. Del Rosso, A. Ungar, R. Maggi, F. Giada, N.R. Petix, T. De Santo, C. Menozzi, and M. Brignole Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score Heart 94 2008 1620 1626
100. M. Rafanelli, E. Ruffolo, V.M. Chisciotti, M.A. Brunetti, A. Ceccofiglio, F. Tesi, A. Morrione, N. Marchionni, and A. Ungar Clinical aspects and diagnostic relevance of neuroautonomic evaluation in patients with unexplained falls Aging Clin Exp Res 26 2014 33 37
101. J.J. Blanc Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation? Prog Cardiovasc Dis 55 2013 418 424
102. D.J. Farwell, N. Freemantle, and N. Sulke The clinical impact of implantable loop recorders in patients with syncope Eur Heart J 27 2006 351 356
103. A.D. Krahn, G.J. Klein, R. Yee, J.S. Hoch, and A.C. Skanes Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial J Am Coll Cardiol 42 2003 495 501
104. A.D. Krahn, G.J. Klein, R. Yee, and C. Norris Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing Am J Cardiol 82 1998 117 119
105. A.D. Krahn, G.J. Klein, C. Norris, and R. Yee The etiology of syncope in patients with negative tilt table and electrophysiological testing Circulation 92 1995 1819 1824
106. A.D. Krahn, G.J. Klein, R. Yee, T. Takle-Newhouse, and C. Norris Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators Circulation 99 1999 406 410
107. A. Moya, M. Brignole, C. Menozzi, R. Garcia-Civera, S. Tognarini, L. Mont, G. Botto, F. Giada, and D. Cornacchia International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope Circulation 104 2001 1261 1267
108. A. Moya, M. Brignole, and R. Sutton Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope Am J Cardiol 102 2008 1518 1523
109. A. Solano, C. Menozzi, R. Maggi, P. Donateo, N. Bottoni, G. Lolli, C. Tomasi, F. Croci, D. Oddone, E. Puggioni, and M. Brignole Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease Eur Heart J 25 2004 1116 1119
110. M. Brignole, R. Sutton, C. Menozzi, R. Garcia-Civera, A. Moya, W. Wieling, D. Andresen, D.G. Benditt, and P. Vardas International Study on Syncope of Uncertain Etiology (ISSUE) 2 Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope Eur Heart J 27 2006 1085 1092
111. M. Brignole, C. Menozzi, and A. Moya Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial Circulation 125 2012 2566 2571
112. M. Brignole, P. Donateo, and M. Tomaino Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3) Circ Arrhythm Electrophysiol 7 2014 10 16
113. R. Sutton, M. Brignole, and D.G. Benditt Key challenges in the current management of syncope Nat Rev Cardiol 9 2012 590 598
114. V. Kuriachan, R.S. Sheldon, and M. Platonov Evidence-based treatment for vasovagal syncope Heart Rhythm 5 2008 1609 1614
115. A. Vyas, P.D. Swaminathan, M.B. Zimmerman, and B. Olshansky Are treatments for vasovagal syncope effective? A meta-analysis Int J Cardiol 167 2013 1906 1911
116. M. Brignole, M. Disertori, and C. Menozzi Management of syncope referred urgently to general hospitals with and without syncope units Europace 5 2003 293 298
117. R. Sutton Treatment of reflex syncope J Med Diagn Meth 2013 2
118. C.T. Krediet, N. van Dijk, M. Linzer, J.J. van Lieshout, and W. Wieling Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing Circulation 106 2002 1684 1689
119. M. Brignole, F. Croci, C. Menozzi, A. Solano, P. Donateo, D. Oddone, E. Puggioni, and G. Lolli Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope J Am Coll Cardiol 40 2002 2053 2059
120. N. van Dijk, F. Quartieri, J.J. Blanc, R. Garcia-Civera, M. Brignole, A. Moya, and W. Wieling PC-Trial Investigators. Effectiveness of physical counter pressure maneuvers in preventing vasovagal syncope: the Physical Counter pressure Manoeuvres Trial (PC-Trial) J Am Coll Cardiol 48 2006 1652 1657
121. A.H. Madrid, J. Ortega, J.G. Rebollo, J.G. Manzano, J.G. Segovia, A. Sanchez, G. Pena, and C. Moro Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study J Am Coll Cardiol 37 2001 554 559
122. R.S. Sheldon, C.A. Morillo, T. Klingenheben, A.D. Krahn, A. Sheldon, and M.S. Rose Age-dependent effect of beta-blockers in preventing vasovagal syncope Circ Arrhythm Electrophysiol 5 2012 920 926
123. M.A. Salim, and T.G. Di Sessa Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial J Am Coll Cardiol 45 2005 484 488
124. J.J. Romme, N. van Dijk, I.K. Go-Schon, J.B. Reitsma, and W. Wieling Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial) Europace 13 2011 1639 1647
125. N. Samniah, S. Sakaguchi, K.G. Lurie, D. Iskos, and D.G. Benditt Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope Am J Cardiol 88 A7 2001 80 83
126. A. Perez-Lugones, R. Schweikert, and S. Pavia Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study J Cardiovasc Electrophysiol 12 2001 935 938
127. C.R. Ward, J.C. Gray, J.J. Gilroy, and R.A. Kenny Midodrine: a role in the management of neurocardiogenic syncope Heart 79 1998 45 49
128. Z. Qingyou, D. Junbao, and T. Chaoshu The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope J Pediatr 149 2006 777 780
129. S.R. Raj, P.D. Faris, M. McRae, and R.S. Sheldon Rationale for the prevention of syncope trial IV: assessment of midodrine Clin Auton Res 22 2012 275 280
130. G.N. Theodorakis, D. Leftheriotis, E.G. Livanis, P. Flevari, G. Karabela, N. Aggelopoulou, and D.T. Kremastinos Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study Europace 8 2006 193 198
131. T.S. Takata, S.L. Wasmund, M.L. Smith, J.M. Li, J.A. Joglar, K. Banks, R.C. Kowal, R.L. Page, and M.H. Hamdan Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers Circulation 106 2002 1500 1504
132. E. Di Girolamo, C. Di Iorio, P. Sabatini, L. Leonzio, C. Barbone, and A. Barsotti Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 33 1999 1227 1230
133. S.J. Connolly, R. Sheldon, R.S. Roberts, and M. Gent The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope J Am Coll Cardiol 33 1999 16 20
134. R. Sutton, M. Brignole, C. Menozzi, A. Raviele, P. Alboni, P. Giani, and A. Moya Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators Circulation 102 2000 294 299
135. F. Ammirati, F. Colivicchi, M. Santini, D. Syncope Treatment Study I. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial Circulation 104 2001 52 57
136. S.J. Connolly, R. Sheldon, K.E. Thorpe, R.S. Roberts, K.A. Ellenbogen, B.L. Wilkoff, C. Morillo, M. Gent VPS II Investigators Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial JAMA 289 2003 2224 2229
137. A. Raviele, F. Giada, C. Menozzi, G. Speca, S. Orazi, G. Gasparini, R. Sutton, and M. Brignole Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE) Eur Heart J 25 2004 1741 1748
138. S. Sud, G.J. Klein, A.C. Skanes, L.J. Gula, R. Yee, and A.D. Krahn Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope Europace 9 2007 312 318
139. J.C. Deharo, R. Guieu, A. Mechulan, E. Peyrouse, N. Kipson, J. Ruf, V. Gerolami, G. Devoto, V. Marre, and M. Brignole Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity J Am Coll Cardiol 62 2013 1075 1080
140. M. Brignole, J.C. Deharo, L. De Roy, C. Menozzi, D. Blommaert, L. Dabiri, J. Ruf, and R. Guieu Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block J Am Coll Cardiol 58 2011 167 173
141. D. Flammang, T.R. Church, L. De Roy, J.J. Blanc, J. Leroy, G.H. Mairesse, A. Otmani, P.J. Graux, R. Frank, P. Purnode ATP Multicenter Study Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing Circulation 125 2012 31 36
142. K.A. McLeod, N. Wilson, J. Hewitt, J. Norrie, and J.B. Stephenson Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures Heart 82 1999 721 725
143. W.B. Plash, A. Diedrich, I. Biaggioni, E.M. Garland, S.Y. Paranjape, B.K. Black, W.D. Dupont, and S.R. Raj Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics Clin Sci 124 2013 109 114
144. F. Colivicchi, F. Ammirati, A. Biffi, L. Verdile, A. Pelliccia, and M. Santini Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome Eur Heart J 23 2002 1125 1130
145. A.J. Ross, M.S. Medow, P.C. Rowe, and J.M. Stewart What is brain fog? An evaluation of the symptom in postural tachycardia syndrome Clin Auton Res 23 2013 305 311
146. L. Chen, L. Wang, J. Sun, J. Qin, C. Tang, H. Jin, and J. Du Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome Circ J 75 2011 927 931
147. Q. Zhang, H. Jin, L. Wang, J. Chen, C. Tang, and J. Du Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents Med Science Monitor 14 2008 CR199 CR203